Embracing Technology-Enhanced Learning for the CRC Level 1 Programme (September 2020 intake)

Programme Duration: 04 September 2020 to 20 November 2020 

Venue: Zoom (Online)

Organiser: SCRI Academy

SCRI Academy’s 12-week Clinical Research Coordinator (CRC) Level 1 Programme kick-started its first virtual lesson, ‘Introduction to Clinical Trial’ on 4 September 2020, in response to the COVID-19 outbreak. It has welcomed a total of 22 CRC and clinical research personnel from various healthcare institutions.

To ensure continued safe learning without disruption, the Programme has adopted a blended learning approach consisting of e-learning and face-to-face virtual classroom trainings. The shift from physical lessons to a mix of independent online learning and face-to-face training sessions is set to empower the participants with the flexibility to manage their learning progress at their own pace and time. This is also to ensure a safe and supportive learning environment for them amidst the pandemic. Similar to previous intakes, the virtual face-to-face classroom sessions will also incorporate interactive classroom discussions, case scenarios and practice-based activities to reinforce the application of core CRC skills in their operational duties. In addition, the Programme trainers will provide a range of opportunities to facilitate participants’ sharing of their experiences and insights for peer-to-peer learning.

The SCRI Academy would like to thank our public healthcare institutions, regulatory authorities and various training partners for their tremendous efforts in collaborating with SCRI Academy to enable a successful commencement of the CRC Level 1 Programme (Blended).

A snapshot of the CRC Level 1 Programme e-learning modules available for participants on the SCRI Academy Learning Management System.

SCRI Academy’s CRC Level 1 Programme trainer, Ms Su Jie, giving an introduction to clinical trials. During the lesson, she and another trainer also spoke on a range of topics including research teams and protocol feasibility.